| Revision as of 18:37, 12 August 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Misplaced Pages:WikiProject Chemicals/Chembox validati← Previous edit |
Latest revision as of 20:34, 1 December 2023 edit undoBuidhe (talk | contribs)Autopatrolled, Extended confirmed users, Page movers, File movers, Mass message senders, New page reviewers, Pending changes reviewers, Template editors136,068 editsm Removing from Category:Monoclonal antibodies using Cat-a-lot |
| (24 intermediate revisions by 16 users not shown) |
| Line 1: |
Line 1: |
|
|
{{Short description|Monoclonal antibody}} |
|
{{drugbox |
|
|
|
{{Drugbox |
|
|
| Verifiedfields = changed |
|
|
| Watchedfields = changed |
|
⚫ |
| verifiedrevid = 458275605 |
|
⚫ |
| image = |
|
|
<!-- Monoclonal antibody data --> |
|
⚫ |
| type = mab |
|
|
| mab_type = mab |
|
⚫ |
| source = u |
|
⚫ |
| target = rabies virus glycoprotein |
|
|
<!-- Clinical data --> |
|
|
| tradename = |
|
⚫ |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
⚫ |
| pregnancy_US = <!-- A / B / C / D / X --> |
|
⚫ |
| pregnancy_category = |
|
⚫ |
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled --> |
|
⚫ |
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
⚫ |
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
|
⚫ |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
⚫ |
| legal_status = |
|
⚫ |
| routes_of_administration = |
|
|
<!-- Pharmacokinetic data --> |
|
⚫ |
| bioavailability = |
|
⚫ |
| protein_bound = |
|
⚫ |
| metabolism = |
|
⚫ |
| elimination_half-life = |
|
⚫ |
| excretion = |
|
|
<!-- Identifiers --> |
|
|
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|
|
| ChemSpiderID = none |
|
|
| CAS_number_Ref = {{cascite|changed|??}} |
|
⚫ |
| CAS_number = 944548-38-3 |
|
⚫ |
| ATC_prefix = none |
|
⚫ |
| ATC_suffix = |
|
⚫ |
| PubChem = |
|
⚫ |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
⚫ |
| DrugBank = |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII = 377VY97V7S |
|
| UNII = 377VY97V7S |
|
|
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
| ⚫ |
| verifiedrevid = 437139177 |
|
|
|
| ChEMBL = 1743021 |
| ⚫ |
| type = mab |
|
|
|
<!-- Chemical data --> |
| ⚫ |
| image = |
|
|
| mab_type = mab |
|
| C=6400 | H=9914 | N=1718 | O=1998 | S=44 |
| ⚫ |
| source = u |
|
| ⚫ |
| target = rabies virus glycoprotein |
|
| ⚫ |
| CAS_number = 944548-38-3 |
|
| ⚫ |
| ATC_prefix = none |
|
| ⚫ |
| ATC_suffix = |
|
| ⚫ |
| PubChem = |
|
| ⚫ |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
| ⚫ |
| DrugBank = |
|
|
| C = 6400 | H = 9914 | N = 1718 | O = 1998 | S = 44 |
|
|
| molecular_weight = 144.3 ] |
|
| ⚫ |
| bioavailability = |
|
| ⚫ |
| protein_bound = |
|
| ⚫ |
| metabolism = |
|
| ⚫ |
| elimination_half-life = |
|
| ⚫ |
| excretion = |
|
| ⚫ |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
| ⚫ |
| pregnancy_US = <!-- A / B / C / D / X --> |
|
| ⚫ |
| pregnancy_category= |
|
| ⚫ |
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
|
| ⚫ |
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
| ⚫ |
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
|
| ⚫ |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
| ⚫ |
| legal_status = |
|
| ⚫ |
| routes_of_administration = |
|
|
}} |
|
}} |
|
'''Foravirumab''' is a ] for the ] of ].<ref>, ''World Health Organization''.</ref> |
|
'''Foravirumab''' is a ] for the ] of ].<ref>, ''World Health Organization''.</ref> It is under development by ]/].<ref>{{cite book| vauthors = Khardori NM |title=Biologic Response Modifiers in Infectious Diseases, An Issue of Infectious Disease Clinics|date=2011|publisher=Elsevier Health Sciences|location=London|isbn=978-1-4557-1207-6|page=158|url=https://books.google.com/books?id=UaHQAQAAQBAJ&q=Foravirumab&pg=PT158}}</ref> |
|
|
|
|
|
== References == |
|
== References == |
| Line 38: |
Line 51: |
|
{{Monoclonals for infectious disease and toxins}} |
|
{{Monoclonals for infectious disease and toxins}} |
|
|
|
|
|
|
] |
|
|
|
|
|
{{antiinfective-drug-stub}} |
|
{{monoclonal-antibody-stub}} |
|
{{monoclonal-antibody-stub}} |
|
|
|
|
] |
|